Chronic renal failure screening

Jump to navigation Jump to search

Chronic renal failure Microchapters


Patient Information


Historical Perspective




Differentiating Chronic renal failure from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings


X Ray



Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic renal failure screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Chronic renal failure screening

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic renal failure screening

CDC on Chronic renal failure screening

Chronic renal failure screening in the news

Blogs on Chronic renal failure screening

Directions to Hospitals Treating Chronic renal failure

Risk calculators and risk factors for Chronic renal failure screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]


The burden of chronic renal disease is not only limited to its implications for replacement therapies such as dialysis or organ transplant, but it also has an impact on the overall population's health and costs. In fact, patients with chronic renal disease include those who are at risk for the progression of renal disease and the development of overt end stage renal disease. These patients have a high likelihood of developing a cardiovascular disease.

Hence, the objective of screening in these patients is for the early detection of asymptomatic diseases, at a time when intervention has a reasonable potential to have an impact on the outcome of the disease course.


Currently, screening for chronic renal failure is only accepted in patients with diabetes and hypertension. Some of the tests frequently used for screening are as follows:

Various antibody based screening tests are also available, but are not used routinely as they require expensive laboratory facilities.


  1. 1.0 1.1 Perico N, Bravo RF, De Leon FR, Remuzzi G (2009). "Screening for chronic kidney disease in emerging countries: feasibility and hurdles". Nephrol. Dial. Transplant. 24 (5): 1355–8. doi:10.1093/ndt/gfp039. PMID 19218536. Unknown parameter |month= ignored (help)
  2. Hallan SI, Dahl K, Oien CM; et al. (2006). "Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey". BMJ. 333 (7577): 1047. doi:10.1136/bmj.39001.657755.BE. PMC 1647344. PMID 17062598. Unknown parameter |month= ignored (help)

Template:WH Template:WS